C-Reactive Protein in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and Relationship with Ventricular Tachycardia

Table 1

Baseline characteristics of patients with ARVD/C and RVOT tachycardia.

	ARVD/C (𝑛=60) Mean ± SD	RVOT tachycardia (𝑛=31) Mean ± SD	𝑃 value
Age (years)	39 ± 14	38 ± 12	.631
Male (%)	85	48	.0002
Hypertension (%)	8	0	.123
Hypercholesterolemia (%)	4	12	.209
Smokers (%)	17	19	.871
RV dysfunction (%)	23	0	.004
Statin (%)	5	0	.206
Aspirin (%)	3	3	.978
Documented VT (%)	77	100	.037
VT-R	195 ± 46	182 ± 41	.374
ICD	38	10	.006
CRP measured <24 h following VT (%)	37	34	.864

ARVD/C, Arrhythmogenic right ventricular dysplasia/cardiomyopathy; RVOT, Right ventricular outflow tract; RV, Right ventricular; VT, Ventricular tachycardia; VT-R, Ventricular tachycardia rate; ICD, Implantable cardioverter-defibrillator; CRP, C-reactive protein.